After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Encompass Health and Piedmont announce plans to build a 40-bed inpatient rehabilitation hospital in Loganville, Georgia.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Encompass Health Corp is listed on the NYSE in the Healthcare sector while operating in the Medical Care Facilities industry. At the end of the last regular session, the stock closed at $76.95 and fluctuated between $76.96 as its day high and $75.32 as its day low. The current market capitalization of Encompass Health Corp is $7.71B. A total of 0.6 million shares were traded on the day, compared to an average of 606.96K shares.
In the most recent transaction, COLTHARP DOUGLAS E sold 11,215 shares of EHC for 63.39 per share on Nov 13 ’23. After the transaction, the EVP & Chief Financial Officer now owns 116,293 company shares. In a previous transaction on Aug 17 ’23, Charbonneau Elissa Joy sold 8,294 shares at 69.58 per share. EHC shares that Chief Medical Officer owns now total 23,081.
Among the insiders who sold shares, Tarr Mark J disposed of 25,330 shares on Aug 16 ’23 at a per-share price of $71.06. This resulted in the President & CEO holding 497,405 shares of EHC after the transaction.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Encompass Health Corp pays an annual dividend of $0.60, resulting in a dividend yield of 0.78%, and it has a price to earnings (P/E) ratio of 22.13. EHC’s most recent ex-dividend date was 3/28/2024 when it declared a $0.15 quarterly dividend that was paid in cash on 4/15/2024. Previously, the company paid the dividend on 1/16/2024 with an ex-dividend date of 12/29/2023. The EHC stock dividend was $0.15 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, EHC has a high of $78.11 and a low of $51.15.
As of this writing, EHC has an earnings estimate of $0.93 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $1.01 per share and a lower estimate of $0.88. The company reported an EPS of $0.86 in the last quarter, which was 11.70% higher than expectations of $0.77.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EHC’s latest balance sheet shows that the firm has $49.40M in Cash & Short Term Investments as of fiscal 2021. There were $3.48B in debt and $748.80M in liabilities at the time. Its Book Value Per Share was $16.43, while its Total Shareholder’s Equity was $2.40B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EHC is Buy with a score of 4.90.
